New Zealand News Beep | NewsBeep.com
  • News Beep
  • New Zealand
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology
New Zealand News Beep | NewsBeep.com
New Zealand News Beep | NewsBeep.com
  • News Beep
  • New Zealand
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology

Browsing Category

Health

50578 posts
MMedication
Woman Details Losing Vision After Taking Wegovy As Patients Sue GLP-1 Drug Companies
Read More

Woman Details Losing Vision After Taking Wegovy As Patients Sue GLP-1 Drug Companies

  • September 22, 2026
Hundreds of Americans are suing the makers of popular GLP-1 weight-loss and diabetes drugs, saying they weren’t adequately…
FFitness
The Best Strength Training Exercises If You’re on a GLP-1, Recommended by an Expert
Read More

The Best Strength Training Exercises If You’re on a GLP-1, Recommended by an Expert

  • September 22, 2026
About 11% of Americans are taking a GLP-1 medication, up considerably from 3% in 2024, according to a…
HHealth
Kneeling gardener holding freshly dug potatoes over soil beside a garden fork
Read More

Could a Potato Be the Key to New IBD Treatments?

  • September 22, 2026
For writer and speaker Amber Tresca, ulcerative colitis — an intestinal disorder — meant planning every moment of…
MMedication
Narcan vending machine nears 800 uses
Read More

Narcan vending machine nears 800 uses

  • September 22, 2026
Narcan vending machine nears 800 uses Published 10:00 am Tuesday, September 22, 2026 A Narcan vending machine installed…
HHealthcare
At 90, this doctor still starts work at 8 AM and climbs steep hills to treat patients: Why he refuses to retire |
Read More

At 90, this doctor still starts work at 8 AM and climbs steep hills to treat patients: Why he refuses to retire |

  • September 22, 2026
Dr Kiril Apostolov, a 90-year-old general practitioner in Bulgaria’s mountain village of Skrat, continues to see more than…
MMental health
After Crucial Paramount Agreement Come Relief, Anger and Concern
Read More

After Crucial Paramount Agreement Come Relief, Anger and Concern

  • September 22, 2026
But some union leaders seemed to seek to toe the line. The leaders of SAG-AFTRA, which represents approximately…
NNutrition
Nutritional yeast is having a moment. Here’s why
Read More

Nutritional yeast is having a moment. Here’s why

  • September 22, 2026
Nutritional yeast’s properties are intriguing food manufacturers, who are increasingly experimenting with it as a functional ingredient for…
FFitness
Alison Hammond, 51, made exercise a habit with this simple trick: ‘It changes how I feel inside’
Read More

Alison Hammond, 51, made exercise a habit with this simple trick: ‘It changes how I feel inside’

  • September 22, 2026
Feel like you’re putting in the work and not seeing results? According to Alison Hammond’s PT, it could…
HHealth
New scanning method detects basal cell carcinoma early using AI
Read More

New scanning method detects basal cell carcinoma early using AI

  • September 22, 2026
Researchers at FAU combine optical diagnosis method with AI-assisted image recognition. Until now, diagnosing skin tumors has relied…
MMedication
Exelixis (EXEL) Gets FDA Review Extension For Zanzalintinib განაცხად tometastatic Colorectal Cancer
Read More

Exelixis (EXEL) Gets FDA Review Extension For Zanzalintinib განაცხად tometastatic Colorectal Cancer

  • September 22, 2026
Exelixis (NasdaqGS: EXEL) said the FDA has extended its review of zanzalintinib plus atezolizumab for metastatic colorectal cancer.…
FFitness
How Nigella Lawson lost 2 stone with 'slow' exercise: 'I have never been on a diet'
Read More

How Nigella Lawson lost 2 stone with ‘slow’ exercise: ‘I have never been on a diet’

  • September 22, 2026
When reports stated that Great British Bake Off host Nigella Lawson had lost two stone, she was quick…
HHealth
Lorlatinib After Five Years: TP53 and EML4::ALK Variant 3 Refine Prognosis but Do Not Define Benefit in ALK-Positive NSCLC
Read More

Lorlatinib After Five Years: TP53 and EML4::ALK Variant 3 Refine Prognosis but Do Not Define Benefit in ALK-Positive NSCLC

  • September 22, 2026
Long-term follow-up from the global phase II lorlatinib study provides a more mature view of how tumor biology…
New Zealand News Beep | NewsBeep.com
www.newsbeep.com